Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 11,333 · FY2023 7,733 · FY2024 316 — 3-yr total 19,381
Gori-based medical clinic / hospital in central Georgia.
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 82.5% | 82.2% | 81.5% | 78.2% | 72.6% | 74.2% | 82.5% | 80.9% |
| EBITDA Margin | 76.8% | 39.9% | 38.0% | 34.9% | 35.0% | 26.5% | 14.0% | 15.6% |
| EBITDAR | 9,910 | 5,779 | 7,463 | 7,462 | 11,640 | 5,888 | 2,323 | 2,794 |
| EBITDAR Margin | 76.8% | 39.9% | 38.0% | 34.9% | 35.0% | 26.5% | 14.0% | 15.6% |
| EBIT Margin | 72.5% | 34.4% | 32.7% | 30.3% | 30.2% | 19.3% | 9.7% | 8.2% |
| Net Profit Margin | 44.7% | 41.6% | 36.3% | 28.6% | 33.3% | 26.6% | 0.8% | 7.5% |
| Operating Expense % of Sales | 5.7% | 42.3% | 43.5% | 43.3% | 37.7% | 47.7% | 74.3% | 72.8% |
| Returns | ||||||||
| Return on Assets (ROA) | 24.0% | 22.0% | 22.8% | 21.0% | 19.8% | 12.2% | 0.7% | 7.0% |
| Return on Equity (ROE) | 29.0% | 23.5% | 24.0% | 22.9% | 20.7% | 12.5% | 0.8% | 7.8% |
| ROIC [EBIT / Invested Capital] | 106.4% | 31.5% | 39.4% | 39.6% | 24.9% | 11.3% | 11.4% | 10.3% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 82.6% | 93.6% | 95.1% | 91.7% | 95.6% | 97.4% | 89.1% | 89.5% |
| Net Debt | -11,102 | -9,881 | -13,407 | -10,335 | -13,124 | -9,484 | -2,271 | -3,125 |
| Cash & Equivalents | 11,102 | 9,881 | 13,407 | 10,335 | 13,124 | 9,484 | 2,271 | 3,125 |
| Total Debt | N/A | N/A | N/A | N/A | 0 | 0 | N/A | N/A |
| Liquidity & working capital | ||||||||
| Current Ratio | 3.82x | 0.31x | 0.48x | 0.50x | 8.53x | 14.74x | 3.90x | 4.19x |
| Quick Ratio | 3.75x | 0.00x | 0.00x | 0.00x | 8.07x | 13.96x | 3.55x | 3.84x |
| Cash Ratio | 2.66x | 7.72x | 12.36x | 6.76x | 5.37x | 8.97x | 1.13x | 1.53x |
| Total Current Assets | 15,945 | 397 | 522 | 761 | 20,859 | 15,579 | 7,822 | 8,540 |
| Total Current Liabilities | 4,179 | 1,280 | 1,084 | 1,529 | 2,444 | 1,057 | 2,008 | 2,039 |
| Inventory | 270 | 397 | 522 | 761 | 1,124 | 830 | 691 | 711 |
| Trade Receivables | 4,506 | 5,511 | 6,067 | 6,011 | 5,921 | 4,908 | 4,860 | 4,704 |
| Trade Payables | 1,105 | 1,239 | 1,043 | 1,476 | 1,559 | 1,029 | 1,207 | 1,141 |
| Net Working Capital | 11,765 | -883 | -562 | -767 | 18,415 | 14,522 | 5,814 | 6,501 |
| Net Working Capital % of Revenue | 91.1% | -6.1% | -2.9% | -3.6% | 55.3% | 65.4% | 35.0% | 36.2% |
| Trade Working Capital | 3,671 | 4,669 | 5,547 | 5,296 | 5,486 | 4,709 | 4,344 | 4,274 |
| Trade Working Capital % of Revenue | 28.4% | 32.2% | 28.2% | 24.8% | 16.5% | 21.2% | 26.2% | 23.8% |
| Change in Trade Working Capital | N/A | 997 | 878 | -250 | 189 | -777 | -365 | -70 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | 8.40x | 6.50x | 6.98x | 6.11x | 8.11x | 6.90x | 4.21x | 4.82x |
| Days Inventory Outstanding (DIO) | 43.4 | 56.2 | 52.3 | 59.8 | 45.0 | 52.9 | 86.7 | 75.7 |
| Receivables Turnover | 2.86x | 2.63x | 3.24x | 3.55x | 5.62x | 4.52x | 3.41x | 3.81x |
| Days Sales Outstanding (DSO) | 127.4 | 138.8 | 112.6 | 102.7 | 64.9 | 80.7 | 106.9 | 95.7 |
| Payables Turnover | 2.05x | 2.08x | 3.50x | 3.15x | 5.85x | 5.56x | 2.41x | 3.00x |
| Days Payable Outstanding (DPO) | 178.1 | 175.4 | 104.4 | 115.9 | 62.4 | 65.6 | 151.3 | 121.5 |
| Cash Conversion Cycle | -7.2 days | 19.6 days | 60.5 days | 46.6 days | 47.5 days | 68.0 days | 42.2 days | 49.9 days |
| Asset Turnover | 0.54x | 0.53x | 0.63x | 0.73x | 0.59x | 0.46x | 0.90x | 0.92x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | 5,119 | 5,414 | 6,233 | 5,622 | 12,326 | 4,155 | 702 | 2,909 |
| Free Cash Flow (OCF − Capex proxy) | 5,119 | 880 | 6,256 | 5,586 | 11,995 | 5,648 | 1,703 | 1,228 |
| Cash Conversion (OCF / EBITDA) | 51.7% | 93.7% | 83.5% | 75.3% | 105.9% | 70.6% | 30.2% | 104.1% |
| Dividends Declared | 0 | 247 | 3,078 | 9,153 | 11,737 | 11,333 | 7,733 | 316 |
| Dividend Payout Ratio | 0.0% | 4.1% | 43.1% | 149.6% | 105.7% | 191.8% | 5708.0% | 23.3% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →